Advertisement

Echo Therapeutics Inc. is no longer a Massachusetts-based company, officials announced in a release Thursday. The medical technology company has relocated from Franklin to Philadelphia.

The move comes just a few months after Echo landed its most recent funding, taking in $5.5 million led by its majority shareholder Platinum Montaur Life Sciences LLC of New York. At the time, Echo Therapeutics (OTC Bulletin Board: ECTE) said it planned to use the new funds to boost product development, advance clinical studies and apply to “working capital and general corporate purposes.”

SOURCE

Advertisement
Advertisement